Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11291631 Oral cannabinoid formulations

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

April 5, 2022

Patent Application Number

16314569

Date Filed

June 29, 2017

Patent Citations

US Patent 10137095 Use of cannabinoids in the treatment of epilepsy

US Patent 10111840 Use of cannabinoids in the treatment of epilepsy

US Patent 10092525 Use of cannabinoids in the treatment of epilepsy

Patent Citations Received

US Patent 11590087 Cannabidiol-type cannabinoid compound

US Patent 11633369 Use of cannabinoids in the treatment of epilepsy

0

US Patent 11446258 Use of cannabinoids in the treatment of epilepsy

US Patent 11963937 Use of cannabinoids in the treatment of epilepsy

0

US Patent 12102619 Methods of treating tuberous sclerosis complex with cannabidiol and everolimus

0

Patent Primary Examiner

Theodore R. Howell

CPC Code

...

The present invention relates to a cannabinoid containing oral solution. Preferably the oral solution comprises a cannabinoid, a lipid solvent, a sweetener and ethanol, characterised in that the sweetener is an ultrahigh potency sweetener.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11291631 Oral cannabinoid formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.